Antibiotic-resistant bacteria cause more than 2 million infections and 23,000 deaths in the U.S. each year. Researchers at Michigan Medicine are exploring a new approach using engineered nanoparticles to target and destroy harmful bacteria, with early work focusing on one of the most common sources of hospital-acquired infections.
